2766510-90-9

PSMA-SulfoCy7 Chemical Structure
2766510-90-9

Chemical Structure

PSMA-SulfoCy7

  • CAS No.: 2766510-90-9
  • Formula:C90H112ClN13O20S2
  • Molecular Weight:1795.51

InChIKey: RUKQDBVJHBLZJI-RNANNXKZSA-N

SMILES: O=C([C@@H](NC([C@@H](NC(CCC(NCCCCCC(N(CC1=CC(Cl)=CC=C1)CCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O)CC3=CC=C(C=C3)O)NCCCN(N=N4)C=C4CNC(CCCCC[N+](C5=CC=C(C=C5C6(C)C)S(=O)([O-])=O)=C6/C=C/C(CCC/7)=CC7=C\C=C8C(C)(C)C9=CC(S(=O)(O)=O)=CC=C9N/8C)=O

Biological Activity: PSMA-SulfoCy7 is a high-affinity imaging agent targeting PSMA/GCPII (with a Ki of 18.1 nM for human PSMA). PSMA-SulfoCy7 regulates PSMA-dependent NAAG hydrolysis. PSMA-SulfoCy7 exhibits excellent in vivo imaging capability, enabling clear visualization of PSMA-expressing tumors in xenograft models, with no obvious toxicity even at a dose of 87.9 mg/kg. PSMA-SulfoCy7 is widely used in prostate cancer-related studies[1].

Cat. No. Product Name Purity Description Pricing
HY-D3353
PSMA-SulfoCy7 PSMA-SulfoCy7 is a high-affinity imaging agent targeting PSMA/GCPII (with a Ki of 18.1 nM for human PSMA). PSMA-SulfoCy7 regulates PSMA-dependent NAAG hydrolysis. PSMA-SulfoCy7 exhibits excellent in vivo imaging capability, enabling clear visualization of PSMA-expressing tumors in xenograft models, with no obvious toxicity even at a dose of 87.9 mg/kg. PSMA-SulfoCy7 is widely used in prostate cancer-related studies.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References